A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone-Reference-Cited by-同舟云学术

A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone

Published:1991-08 Issue:8 Volume:27 Page:954-958
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Lewington Valerie J.,McEwan Alexander J.,Ackery Duncan M.,Bayly Russell J.,Keeling David H.,Macleod Patricia M.,Porter Arthur T.,Zivanovic Maureen A.

Publisher

Elsevier BV

Subject

Oncology

Reference15 articles.

1. The extent of current staging procedures in assessing disease extent of prostatic adenocarcinoma;Paulson;J Urol,1979

2. Treatment of newly diagnosed metastatic prostate cancer with chemotherapy agents in combination with hormones versus hormones alone;Murphy;Cancer,1983

3. Bone metastases-prognosis, diagnosis and treatment;Lote;Acta Oncol,1986

4. Single dose half body irradiation for pallition of multiple bone metastases from solid tumors;Salazar,1986

5. Treatment of metastatic bone pain with strontium-89;Robinson;Nucl Med Biol,1987

Cited by 248 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Primer on Radiopharmaceutical Therapy;International Journal of Radiation Oncology*Biology*Physics;2023-01

2. Team Approach: Management of Pathologic Fractures;JBJS Reviews;2023-01

3. Targeting signaling pathways in prostate cancer: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-06-24

4. Targeted Radionuclide Therapy for Bone Metastasis;Nuclear Oncology;2022

5. Targeted Radionuclide Therapy for Bone Metastasis;Nuclear Oncology;2022